Tag Archives: Fluctuation Assessment Scales

Dementia Revealed: Dementia Guide / Toolkit for GPs (NHS England / Department of Health / RCGP)

Posted on September 17, 2014 by Dementia and Elderly Care News

Summary NHS England has a commitment to improve dementia diagnosis rates. NHS England has published a guide to help GPs perform better on the timely diagnosis of dementia and to offer advice on post-diagnostic support for the person with the … Continue reading →

Posted in Alzheimer's Society, Antipsychotics, Charitable Bodies, Commissioning, Community Care, Delirium, Department of Health, Diagnosis, End of Life Care, Falls, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NHS England, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK, Universal Interest | Tagged 4AT Score, 4AT Screening Instrument for Rapid Initial Assessment of Delirium and Cognitive Impairment, Abbreviated Mental Test Score (AMTS), ACE III: Modified Addenbrooke’s Test, Activities of Daily Living (ADLs), Acute Change or Fluctuating Course, Addenbrooke's Cognitive Examination (ACE), Advance Decision to Refuse Treatment (ADRT), Advance Directives, Agitation, Alcohol Consumption, Alcohol Misuse, Alistair Burns: NHS England’s National Clinical Director for Dementia, Alternatives to Medication for Agitation, AMT4 (Abbreviated Mental Test - 4), Anticholinergic Drugs, Anticholinergics, Antipsychotics Limitation in Dementia, Antipsychotics: Neuroleptic Sensitivity, AT4 (Delirium Scale), Behavioural and Psychological Symptoms of Dementia (BPSD), Benefits Advice, Benzodiazepines, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Care Homes, Caregiver Assessments, Carers' Assessments, Clomethiazole, Coding of Dementia, Cognitive Stimulation Therapy (CST), Dementia and Alcohol, Dementia and Driving Guidance, Dementia Coding, Dementia Diagnosis Rates, Dementia Prevalence Calculator, Dementia Revealed: Dementia Guide for GPs, Dementia Toolkit for GP Commissioners, Dementia Toolkit for GPs, Deprivation of Liberty Safeguards (DoLS), Diagnosis and Assessment, Diagnosis and Referral, Diagnosis and Support, Diagnosis at Primary Care Level, Dr Elizabeth Barrett: Shires Health Care (Hardwick CCG), Driving, Driving and Dementia, Early Diagnosis, Fluctuation Assessment Scales, Fluctuations, General Practice, General Practice in England, General Practices, General Practitioner Assessment of Cognition (GPCOG), Geriatric Depression Scale, GPCog (The General Practitioner assessment of Cognition), GPs' Dementia Toolkit, IMCAs and Safeguarding, Improving Coding, Improving Dementia Diagnosis Rates, Improving General Practice, Inappropriate Use of Antipsychotics in Dementia, Independent Mental Capacity Advocates (IMCAs), Lasting Power of Attorney (LPoA), Lorazepam, Low Dose Antipsychotics, Managing Agitation, Memantine, Memory Clinics, Mini Mental State Examination (MMSE), Mirtazapine, Montreal Cognition Assessment (MOCA), NHS Continuing Care, NHS Hardwick CCG, Post-Diagnosis Support, Post-Diagnostic Support, Primary Care, Professor Alistair Burns, Quetiapine, RCGP, Risperidone, Rivastigmine, Royal College of General Practitioners (RCGP), Safeguarding Vulnerable Adults, Sertraline, Shires Health Care, Simon Stevens: Chief Executive of NHS England (2014-), Social Services, Support for Improving Dementia Diagnosis Rates, Temazepam, Timely Diagnosis, Trazodone, Voluntary Organisations, Wernicke-Korsakoff Syndrome, Zopiclone | Leave a comment

SPECT Imaging of Suspected Dementia with Lewy Bodies (BMJ Open)

Posted on April 21, 2013 by Dementia and Elderly Care News

Summary This article reviews progress in the use of Single-Photon Emission Computed Tomography (SPECT) for the diagnosis of Dementia with Lewy Bodies (DLB). The authors conclude that systematic visual analyses of ((123)I)FP-CIT SPECT images may be used to detect people … Continue reading →

Posted in Acute Hospitals, Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Quick Insights, Systematic Reviews | Tagged (123)I-FP-CIT: (123)I-2beta-carbometoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane, (123I)FP-CIT SPECT, Acting Out Dreams: Rapid Eye Movement (REM) Sleep Behaviour Disorder, Aβ Deposition in DLB, Amyloid Beta Protein, Applied Radiology, BMJ Open, Brain Imaging, Centre for Age-Related Medicine: Stavanger University Hospital, Clinically Uncertain Parkinsonism Syndrome Study, Clinician Assessment of Cognitive Fluctuations (COGA), Computed Tomography (CT), Dementia in Parkinson's Disease, Dementia with Lewy Bodies, Dementia With Lewy Bodies (DLB), Dementia with Lewy Bodies Symptoms, DemWest Database, DemWest Study, Department of Psychiatry: Stavanger University Hospital, Diagnosis and Screening: Dementia with Lewy Bodies, Differential Diagnosis, Disease Predictors, DLB, DLB: Dementia with Lewy Bodies, Dream Enactment Behaviour During Sleep, Dreaming in Dementia: REM Sleep Behaviour Disorder and Synucleinopathy, Early Diagnosis, Early Differential Diagnosis, Fluctuating Cognition, Fluctuation Assessment Scales, FP-CIT Binding to DAT and SERT, Lewy Body Degeneration, Lewy Body Dementia, Lewy-Related Pathologies (LRP), Magnetic Resonance Imaging (MRI), Mayo Fluctuation Questionnaire, Mayo Sleep Questionnaire, Montreal General Hospital, MRI, MRI Brain Imaging, MRI Scans, Neurodegeneration, Neurodegenerative Diseases, Norway, Parkinson’s Disease Dementia, Parkinsonism, PDD: Parkinson's Disease with Dementia, Rapid Eye Movement (REM) Sleep, Rapid Eye Movement (REM) Sleep Behaviour Disorder, Rapid Eye Movement (REM) Sleep Disorder, Rapid Eye Movement Sleep Behaviour Disorder (RBD), RBD: Rapid Eye Movement Sleep Behaviour Disorder, REM Sleep Behaviour Disorder, S−CF+ Cases, Single Photon Emission Computed Tomography (SPECT), Single-Photon Emission Computed Tomography (SPECT or Less Commonly SPET), Sleep Disorders, SPECT, Stavanger University Hospital; Norway, Synucleinopathy, Visual Hallucinations, Visually Rated ((123)I)FP-CIT SPECT | Leave a comment

Issues in the Clinical Diagnosis of Dementia with Lewy Bodies (Translational Neurodegeneration)

Posted on February 24, 2013 by Dementia and Elderly Care News

Summary This article discusses recent progress, and problems remaining, in the clinical diagnosis of Dementia with Lewy Bodies (DLB). The sensitivity of accurate clinical diagnosis of DLB is said to be low. It seems likely that it may be possible … Continue reading →

Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Universal Interest | Tagged (123)I-FP-CIT: (123)I-2beta-carbometoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane, Aβ Deposition in DLB, Amyloid Beta Protein, Antipsychotics: Neuroleptic Sensitivity, Assessment of Fluctuation Scales, Australia, Beta-Amyloid, Beta-Amyloid Plaques, CIND-PD: Cognitive Impairment in Parkinson's Disease, Cognitive Impairment in Parkinson's Disease, Cognitive Impairment in Parkinson's Disease (CIND-PD), DaTSCAN, Delusional Ideas, Delusions, Dementia in Parkinson's Disease, Dementia with Lewy Bodies, Dementia With Lewy Bodies (DLB), Dementia with Lewy Bodies Symptoms, Dementia with Lewy Bodies Translational Neurodegeneration, Diagnosis and Management of Dementias of Lewy Body Type in the NHS (DIAMAND-Lewy), Diagnosis and Screening: Dementia with Lewy Bodies, Differential Diagnosis, DLB: Dementia with Lewy Bodies, Dopamine, Dopamine Denervation, Early Differential Diagnosis, Fluctuating Cognition, Fluctuation Assessment Scales, Frederick Lewy, Genetics of DLB, Glucocerebrosidase Gene Mutations, Hallucinations, Hallucinations in People with Dementia, I-123 MIBG: Iodine-123 Metaiodobenzilguanidine, α-Synuclein, β-amyloid, β-amyloid Deposition, β-Amyloid Oligomerization, β-Synuclein, γ-Synuclein, Lewy Body Degeneration, Lewy Body Dementia, Lewy-Related Pathologies (LRP), Low Dopamine Transporter Uptake, LRP: Lewy-Related Pathology, Neuroleptic Sensitivity, Neuroscience Research Australia, Parkinson’s Disease Dementia, PDD: Parkinson's Disease with Dementia, Severe Neuroleptic Sensitivity, SPECT, Sydney, University of New South Wales, Visual Hallucinations | Leave a comment

Tag Archives: Fluctuation Assessment Scales

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites